Advertisement
Skip to Content

Viatris Inc VTRS Stock Quote

| Rating as of

NASDAQ: VTRS

Last close prices updated as of Jan 27, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 11.89
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Mid Value
  • Day Range 11.82  –  12.09
  • Year Range 8.42  –  15.60
  • Market Cap 14.4188 Bil
  • Volume / Avg 9.9 Mil /  9.4 Mil
  • Price / Sales 0.86
  • Price / Book 0.75
  • Forward Div Yield 4.17%
  • Trailing Div Yield 4.04%

Morningstar‘s Stock Analysis VTRS

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics VTRS

Company Profile VTRS

Business Description

Formed by the combination of Mylan and Pfizer’s Upjohn business in 2020, Viatris is one of the world’s largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company’s branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Contact
1000 Mylan Boulevard
Canonsburg, PA, 15317
Industry Drug Manufacturers - Specialty & Generic
Employees 37,000

Related Articles VTRS

FAQs for Viatris Inc Stock

Yes. VTRS has a forward dividend yield of 4.17%. See VTRS’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

VTRS’s market cap is 14.42 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

VTRS’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

VTRS’s price/sales is 0.86.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

VTRS’s price/forward earnings is 3.58.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

VTRS’s price/book is 0.75.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See VTRS’s valuation ratios compared to the Market Index.

VTRS’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare VTRS’s historical performance against its industry peers and the overall market.